Openbookopenbook
Openbook
XLV
+12.62 · +8.77%
$156.41 · NYSE ARCA

Health Care Select Sector SPDR® Fund (XLV) ETF Analysis | Health

State Street Investment Management · United States
AUM:$43.1B
#– of – in Health ETFs

Educational tool only – Figures are based on historical data, holdings and expense metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Market Performance

Up 9.4% over the past year, showing positive momentum.

Cost Efficiency

Ongoing charge of 0.09% — among the lowest available for this category.

What is XLV?

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index.

Performance Highlights

Returns (%)
Top Sectors (%)

Investment Breakdown

Positive 1-Year Return
XLV returned 9.4% over the past year. Historical returns only — past performance is not indicative of future results.
Ultra-Low Expense Ratio
Expense ratio of 0.09% — among the lowest available. Low costs compound favourably over long holding periods.
Concentrated Holdings
Top 10 holdings account for 58.1% of the ETF — significant weight in a small number of names.
ETF Information
AUM$43.1B
Expense Ratio0.09%
Dividend Yield1.60%
Holdings50
Inception DateDec 1998
DomicileUnited States
DistributionNA
Index–
ProviderState Street Investment Management
Beta0.68
CategoryHealth
CurrencyUSD
Portfolio Impact

How would XLV affect your portfolio?

Sign in to see exactly what adding this ETF changes — sector exposure, yield, diversification, volatility. Real numbers from your actual holdings.

Sign in
Example preview
6168
+7 points · better diversified

Chart Tools

My Portfolio

Sign in to overlay your portfolio on the chart.

Sign in
Compare Equity
Uses ISF.L (iShares FTSE 100 ETF)
Indicators

Performance Metrics

Historical returns

6M
+7.3%
1Y
+27.1%
3Y
+32.8%
5Y
+37.2%
OpenBook InsightIf you had invested £10,000 in XLV 5 years ago, it would have grown to £13,725 — a gain of £3,725.

Annual Returns

Calendar year performance

XLV delivered positive returns in 4 of the last 5 calendar years.
YearXLV
2026 YTD+10.5%
2025+14.5%
2024+0.7%
2023+2.4%
2022-1.1%
CAGR 4yr+3.9%
4/5 positive yearsAvg return: +5.4%Worst year: -1.1% (2022)

Technical Analysis Summary

Automated insights from historical price action and indicators

Technical Regime: POSITIVE
Trend Strength
100%
Positive
Volatility
18.2%
Low
Momentum
+7.5%
30-day change
Support Level
162.10
Key floor
Key Insights
  • Price is currently trading above all key moving averages.
  • Monitor key support and resistance levels as part of broader risk assessment.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.